Christos Chouaid

65PUBLICATIONS
131CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Oncology and carcinogenesis not elsewhere classifiedMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (65)

|Jul 14, 2026
Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 Study.

|Jun 15, 2026
Challenges for first-line therapy in elderly patients with metastatic non-small cell lung cancer.

|May 25, 2026
Preventing infusion-related reactions: the lessons learn with the use of amivantamab.

|Mar 27, 2026
Real-World Treatment Patterns and Survival in Patients with <i>ROS1</i>-Positive Advanced Non-Small Cell Lung Cancer in Canada and Europe.

Winson Y Cheung, Adam Lee, Helena Bote de Cabo

|Dec 15, 2025
Timing of Immunotherapy in Practice: Feasibility and Impact of Morning Checkpoint Inhibitor Administration.

Pasquale F Innominato, Thierry Landré, Abdoulaye Karaboué

|Nov 26, 2025
Evolving Therapeutic Landscape of ROS1-Positive Non-Small Cell Lung Cancer: An Updated Review.

Hervé Bischoff, Sébastien Gendarme, Laura Somme

Pageof 11

Frequent Collaborators

8 joint publications

Florian Guisier

5 joint publications

Jean-Bernard Auliac

5 joint publications

Thierry Landre

4 joint publications

Jean-Baptiste Assié